SCHEMBL4137313

SCHEMBL4137313

N#Cc1cccc([CH]Cc2ccccc2C#N)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
FBP1 P09467 3/20 0.41
GRIN1 Q05586 3/20 0.40
GRIN2B Q13224 3/20 0.40
GRIN2D O15399 2/20 0.40
GRIN3B O60391 2/20 0.40
GRIN2A Q12879 2/20 0.40
GRIN2C Q14957 2/20 0.40
GRIN3A Q8TCU5 2/20 0.40
ADRA2C P18825 1/20 0.39
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
P4HB P07237 4/20 0.37
TSHR P16473 1/20 0.35
CYP19A1 P11511 1/20 0.35
ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28553209 0.83 CYP19A1 (0.40) ALDH1A1SMN1; SMN2HPGDTSHRCYP19A1
SCHEMBL8668592 0.77 FBP1 (0.45) ALDH1A1FBP1GRIN1GRIN2BGRIN2D
SCHEMBL16619152 0.74 PDCD1 (0.50) FBP1GRIN1GRIN2BGRIN2DGRIN3B
SCHEMBL27336648 0.73 GRIN2D (0.50) FBP1GRIN1GRIN2BGRIN2DGRIN3B
SCHEMBL7331821 0.71 PDCD1 (0.48) FBP1GRIN1GRIN2BGRIN2DGRIN3B
SCHEMBL11256318 0.71 TSHR (0.55) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL9251891 0.70 FBP1 (0.45) FBP1GRIN1GRIN2BGRIN2DGRIN3B
SCHEMBL67236 0.70 FBP1 (0.56) ALDH1A1FBP1GRIN1GRIN2BGRIN2D
SCHEMBL2657662 0.70 FBP1 (0.51) FBP1GRIN1GRIN2BGRIN2DGRIN3B
SCHEMBL29463498 0.70 FBP1 (0.56) ALDH1A1FBP1GRIN1GRIN2BGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137801-A1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137801-A1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS DPP8, DPP4, DPP7 ALDH1A1 276/4885SMN1; SMN2 2069/4885NPC1 1815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.